Back to News
Federal RegisterFederal
Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
Plain English Summary
The proposed rule outlines several changes to Medicare and Medicaid programs that will affect healthcare providers. Key updates include adjustments to the payment rates for services under the Physician Fee Schedule, new policies for the Medicare Prescription Drug Inflation Rebate Program, and changes to the Medicare Shared Savings Program. These updates aim to better align payment systems with current medical practices and ensure that healthcare providers are fairly compensated.
Insurance agents should familiarize themselves with these changes, as they may impact how services are billed and reimbursed. Staying informed will help agents better assist their clients in navigating these updates.
+View original text
This proposed rule addresses: changes to the physician fee schedule (PFS); other changes to Medicare Part B payment policies to ensure that payment systems are updated to reflect changes in medical practice, relative value of services, and changes in the statute; codification of establishment of new policies for: the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; the Ambulatory Specialty Model; updates to drugs and biological products paid under Part B; Medicare Shared Savings Program requirements; updates to the Quality Payment Program; updates to policies for Rural Health Clinics and Federally Qualified Health Centers; update to the Ambulance Fee Schedule regulations; codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2026 provisions; updates to Clinical Laboratory Fee Schedule regulations; updates to the Medicare Promoting Interoperability Program.